Military Airborne Laser Market 2030 Size Worth Witness USD 14-03-2023, 21:32

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00

GOLFTEC Announces New Game Improvement Ad Campaign 27-02-2023, 22:49